Evidence map›Paper›PMID 29361731›Full record

ArticleInternational journal of molecular sciences2018

In Vitro Antitumor Activity of Aloperine on Human Thyroid Cancer Cells through Caspase-Dependent Apoptosis.

Ying-Ray Lee, Shu-Hsin Chen, Ching-Yen Lin, Wen-Ying Chao, Yun-Ping Lim, Hui-I Yu, Chieh-Hsiang Lu

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.

  1. The Changing Face ofFrontiers in surgery · 2020
    Pooled it
  2. Review
  3. The impact of evodiamine on human anaplastic thyroid cancer therapy-anInternational journal of medical sciences · 2025
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Molecular medicine reports · 2021
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Ying-Ray LeeDepartment of Medical Research, Ditmanson Medical Foundation Chiayi Christian Hospital, Chiayi 600, Taiwan. yingray.lee@gmail.com.ORCID 0000-0002-0349-0960
Shu-Hsin ChenDepartment of Medical Research, Ditmanson Medical Foundation Chiayi Christian Hospital, Chiayi 600, Taiwan. cych10472@gmail.com.
Ching-Yen LinDepartment of Medical Research, Ditmanson Medical Foundation Chiayi Christian Hospital, Chiayi 600, Taiwan. jouyuan22@gmail.com.
Wen-Ying ChaoDepartment of Nursing, Min-Hwei College of Health Care Management, Tainan 736, Taiwan. april@mail.mhchcm.edu.tw.
Yun-Ping LimDepartment of Pharmacy, College of Pharmacy, China Medical University, Taichung 404, Taiwan. limyp@mail.cmu.edu.tw.
Hui-I YuDivision of Endocrinology and Metabolism, Department of Internal Medicine, Ditmanson Medical Foundation Chiayi Christian Hospital, Chiayi 600, Taiwan. 04490@cych.org.tw.
Chieh-Hsiang LuDivision of Endocrinology and Metabolism, Department of Internal Medicine, Ditmanson Medical Foundation Chiayi Christian Hospital, Chiayi 600, Taiwan. 02602@cych.org.tw.
Chia-Yi Christian Hospital · TWMin-Hwei College of Health Care Management · TWAsia University · TWChina Medical University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The global incidence of thyroid cancer, one of the most common endocrine malignancies, is especially high among women. Although most patients with thyroid cancers exhibit a good prognosis with standard treatment, there are no effective therapies for patients with anaplastic thyroid cancers or cancers that have reached an advanced or recurrent level. Therefore, it is important to develop highly effective compounds for treating such patients. Aloperine, a natural compound isolated from

Indexed as

Antineoplastic AgentsApoptosisBiomarkersCaspasesCell CycleCell Line, TumorCell ProliferationCell Transformation, NeoplasticFlow CytometryHumansPiperidinesProto-Oncogene Proteins c-aktQuinolizidinesSignal TransductionThyroid NeoplasmsaloperineAntineoplastic AgentsBiomarkersCaspasesPiperidinesProto-Oncogene Proteins c-aktQuinolizidinesaloperineapoptosisthyroid cancer

Identifiers

PMID29361731
PMCPMC5796256
OpenAlexW2791028904

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.